Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Kathy Oubre, MS, considers how comfortable physicians and payers are with biosimilars

Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, considers how comfortable physicians and payers are with biosimilars

Tags: BiosimilarsCOA Conference CoverageFDA/Regulatory (includes NICE, EMA, CHMP, Biosimilars, Generics)

Published: 21 April 2021

Recent Videos: COA Conference Coverage

video

Kathy Oubre, MS, considers how comfortable physicians and payers are with biosimilars

Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, considers how comfortable physicians and payers are with biosimilars

video

Kathy Oubre, MS, speculates on the future of biosimilars

Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, speculates on the future of biosimilars

video

Kathy Oubre, MS, offers opinion on whether biosimilars are living up to their estimated cost savings

Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, offers opinion on whether biosimilars are living up to their estimated ...

video

Kathy Oubre, MS, comments on the recent criticism regarding the use of biosimilars

Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, comments on recent criticisms surrounding biosimilars

video

Bo Gamble, on the most important critical success factors when adopting a new payment model

Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, offers opinion on the most important critical success factors when ...

video

Alti Rahman, MHA\MBA, CSSBB, reflects on social determinants of health in cancer care

Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, reflects on social determinants of health and considers how an oncology practice ...

video

Bo Gamble, discusses the impact of consolidation on the delivery of cancer care

Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, discusses the impact of consolidation on the delivery of cancer ...

video

Bo Gamble, speculates on the future of alternative payment models (APMs)

Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, speculates on the future of alternative payment models (APMs) and ...

video

Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape

Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, offers advice to oncology practices looking to succeed in today's landscape of ...

video

Alti Rahman, MHA\MBA, CSSBB, regarding the impact of consolidation on the delivery of cancer care

Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, regarding the impact of consolidation on the delivery of cancer care

Related Videos

video-image

Kathy Oubre, MS, speculates on the future of biosimilars

video-image

Kathy Oubre, MS, offers opinion on whether biosimilars are living up to their estimated cost savings

video-image

Kathy Oubre, MS, comments on the recent criticism regarding the use of biosimilars

video-image

Bo Gamble, on the most important critical success factors when adopting a new payment model

video-image

Alti Rahman, MHA\MBA, CSSBB, reflects on social determinants of health in cancer care

video-image

Bo Gamble, discusses the impact of consolidation on the delivery of cancer care

video-image

Bo Gamble, speculates on the future of alternative payment models (APMs)

video-image

Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape

video-image

Alti Rahman, MHA\MBA, CSSBB, regarding the impact of consolidation on the delivery of cancer care

video-image

Bo Gamble, considers how value & quality may vary across community oncology practices

video-image

Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

video-image

Alti Rahman, MHA\MBA, CSSBB, considers how oncology practices can reduce costs & maximize savings

video-image

Alti Rahman, MHA\MBA, CSSBB, provides perspective on the challenges facing oncology practices

video-image

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

video-image

Johnetta Blakely, MD, offers an example of how HEOR has impacted cancer care at Tennessee Oncology

video-image

Johnetta Blakely, MD, elaborates on how HEOR may be used in conjunction with real-world evidence

video-image

Johnetta Blakely, MD, considers how HEOR data influences payer decisions

video-image

Johnetta Blakely, MD, explains the role of HEOR as it contributes to value-based care

video-image

Jonathan E. Levitt, Esq., considers how PBM behaviors are changing as a result of the pandemic

video-image

Jonathan E. Levitt, Esq., offers opinion on PBM consolidation & the changing dynamics of cancer care

video-image

Jonathan E. Levitt, Esq., explains how copay aggregators differ across PBMs

video-image

Jonathan E. Levitt, Esq., on the experience of hem/onc groups unable to enter into a PBM network

video-image

Jonathan E. Levitt, Esq., explains how DIR fees impact practice costs and efficiencies

video-image

Jonathan E. Levitt, Esq., discusses the state of payer mandates for white / brown bagging

video-image

Sara Riordan, MS, CGC, on the role of genetic counselors as part of a multidisciplinary cancer team

video-image

Sara Riordan, MS, CGC, regarding the significance of biomarker testing in early-stage cancer

video-image

Sara Riordan, MS, CGC, on how genetic signature & biomarker tests are used in cancer management

video-image

Sara Riordan, MS, CGC, elaborates on the unmet needs in biomarker testing

video-image

Lalan S. Wilfong, MD, discusses key takeaways from the 2021 Virtual Community Oncology Conference

video-image

Lalan S. Wilfong, MD, regarding the impact of geographic location on the delivery of cancer care

video-image

Lalan S. Wilfong, MD, considers the impact of the Oncology Care First model

video-image

Lalan S. Wilfong, MD, offers opinion on the key success factors for new payment reform models

video-image

Lalan S. Wilfong, MD, speculates on the future of oncology medical homes

video-image

Tomasz Beer, MD, FACP, discusses the recently FDA approved relugolix

video-image

Robert Coleman, MD, FACOG, FACS, discusses the 2 recent FDA approvals for PARP inhibitors in ovarian cancer